eli lilly and company news

Eli Lilly's (NYSE:LLY) Dividend Will Be Increased To $1.50

The board of Eli Lilly and Company ( NYSE:LLY ) has announced that it will be paying its dividend of $1.50 on the

Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know

Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past month,

The Motley Fool · 8d

Is Eli Lilly Stock a Buy?

Eli Lilly's stock has been a strong winner over the past few years, powered by its portfolio of glucagon-like peptide-1 (GLP-1) receptor agonist drugs. The stock is up about 36% year to date as of this writing and has gained around 506% over the past five years.

MarketWatch · 3d

Eli Lilly & Co. stock outperforms competitors on strong trading day

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy. Back To Top

24/7 Wall St · 3d

Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 484.64% and currently trading at $772.95. The company has been around since 1876 and the stock didn’t go public until 1952 but in the last 4 years,

5don MSN

Drug-Trial Results Could Shake Up Pharma Stocks in 2025. Watch Eli Lilly, Pfizer, and More.

Here are some clinical trials that could send Big Pharma shares soaring, or crashing, in 2025. Eli Lilly. The world’s biggest ...

10d

Better Buy: Eli Lilly vs. Novo Nordisk. The Answer Is Becoming Abundantly More Clear.

Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the clear-cut winner for ...

Yahoo Finance2d

Eli Lilly and Company (LLY)

Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved Zepbound® (tirzepatide) as the first and only prescription medicine for adults with ...

Pharmaceutical Technology17h

LY-4052031 by Eli Lilly and Co for Ovarian Cancer: Likelihood of Approval

LY-4052031 is under clinical development by Eli Lilly and Co and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase I drugs for Ovarian Cancer have a 73% phase transition success ...

Becker's Hospital Review2d

Eli Lilly to join lawsuit over GLP-1 shortage: 4 things to know

Eli Lilly is joining in a lawsuit filed by the Outsourcing Facilities against the FDA, aiming to reverse the FDA's October 2024 determination that the shortage has been resolved, which would allow ...

FiercePharma2d

Roche projected to claim pharma's 2025 sales crown as Novo, Lilly climb rankings: Evaluate

The story of Eli Lilly and Novo Nordisk’s GLP-1 dominance is likely to play out again in 2025 as the metabolic medicine ...

Pharmaceutical Technology9h

Macupatide by Eli Lilly and Co for Type 2 Diabetes: Likelihood of Approval

Macupatide (LY-3532226) is under development for the treatment of type 2 diabetes, obesity and type 1 diabetes mellitus. It is administered through subcutaneous route. It is a long acting new ...

Insider Monkey6d

Is Eli Lilly and Company (LLY) the Best Pharma Dividend Stock to Buy In 2024?

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other pharma dividend stocks. The pharmaceutical industry in 2024 faced a relatively ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results